Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel ...
MedPage Today on MSN
First-in-Class KRAS-Degrader Promising in Pancreatic, Lung Cancers
"There is a clear unmet need for therapies," researcher says ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
Definitive SBRT in unresectable pancreatic cancer: Long-term outcomes with moderate vs high dose approaches. Use of transcriptomic signatures of RAD51 and GATA6 to predict real-world overall survival ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University of Cincinnati Cancer Center researchers examined the unique tumor ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University of Cincinnati Cancer Center researchers examined the unique tumor ...
A new study from scientists at Boston Medical Center has uncovered an unexpected connection between gallstones and one of the most dangerous cancers in the world—pancreatic cancer. The findings ...
Pancreatic cancer is one of the most serious and deadly forms of cancer. It is often called a “silent” disease because it usually does not cause clear symptoms in its early stages. By the time it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results